IndietroDrug Absorption, Dissolution, and Bioavailability: Biopharmaceutical and Pharmacokinetic Considerations
Guida di studio - Note intelligenti
Appunti personalizzati basati sui tuoi materiali, ampliati con definizioni chiave, esempi e contesto.
Dosage Form Design: Biopharmaceutical and Pharmacokinetic Considerations
Introduction to Drug Absorption and Dosage Forms
Drug absorption is a critical process in pharmacology, determining how a drug enters systemic circulation from its site of administration. The design of pharmaceutical dosage forms aims to optimize drug delivery, stability, and patient compliance.
Drug Absorption: The process by which a drug moves from its site of administration to the site of measurement (usually blood plasma).
Dosage Forms: Mechanisms for safe and convenient delivery of accurate drug doses, including tablets, capsules, solutions, suspensions, creams, and patches.
Excipients: Inactive substances in drug formulations that aid processing, stability, bioavailability, and patient acceptability.
Routes of Administration: Oral, sublingual, intramuscular, topical, inhalation, etc.
Example: Diphenhydramine (Benadryl®) is available as tablets, capsules, liquids, sprays, and creams, each designed for specific routes and patient needs.
Principles of Drug Absorption
Drug absorption depends on the movement of molecules across biological membranes, primarily via passive diffusion or specialized transport mechanisms.
Passive Diffusion: Movement of drug molecules down a concentration gradient without energy expenditure. Governed by molecular size, shape, ionization, and lipid solubility.
Specialized Transport: Includes active transport (energy-dependent, against gradient) and facilitated diffusion (carrier-mediated, down gradient).
Membrane Physiology: Cell membranes are lipid bilayers with embedded proteins, affecting permeability and absorption.
Fick's First Law of Diffusion:
= diffusion coefficient (depends on drug size, solubility, and medium viscosity)
= surface area
= concentration difference across membrane
= membrane thickness
Factors Affecting Oral Drug Absorption
Several physiological, physicochemical, and formulation factors influence the rate and extent of drug absorption from oral dosage forms.
Physiological Factors: Membrane physiology, gastrointestinal (GI) blood flow, gastric emptying time, motility, and the effect of food.
Physicochemical Factors: Drug pKa, lipid solubility, stability, complexation, and adsorption.
Formulation Factors: Dosage form type, excipients, particle size, and hydration state.
pH-Partition Theory: Only the unionized form of a drug can readily cross cell membranes. Weak acids and bases are absorbed depending on the pH of the GI tract and their pKa values.
Weak Acid:
Weak Base:
Example: Aspirin (pKa 3.5) is mostly unionized in the stomach (pH ~1-2), favoring absorption.
Dissolution and Solubility
Dissolution is the process by which a drug dissolves in a solvent, a key step for absorption from solid dosage forms. Solubility is measured by dissolving the drug in 250 mL buffer (pH 1.0-8.0).
Dissolution Rate: Often directly related to absorption rate, especially for poorly soluble drugs.
Noyes-Whitney Equation:
= rate of dissolution
= dissolution rate constant
= surface area of particles
= concentration at particle surface
= concentration in bulk fluid
Factors Influencing Dissolution:
Diffusion layer thickness
Agitation
Solubility and pH
Excipients and bile salts
Particle size and surface area
Physical Forms and Their Impact on Absorption
The physical state of a drug (crystalline vs. amorphous) and its salt form can significantly affect dissolution and bioavailability.
Crystalline Form: Ordered, lowest energy, generally less soluble.
Amorphous Form: Metastable, higher solubility, dissolves more rapidly.
Salts: Salts of weak acids/bases (e.g., potassium, sodium, hydrochloride) are generally more soluble and dissolve faster.
Example: Erythromycin hydrates and anhydrous forms have different solubilities; amorphous chloramphenicol dissolves faster than crystalline forms.
Bioavailability and Bioequivalence
Bioavailability describes the rate and extent to which an active drug ingredient is absorbed and becomes available at the site of action. Bioequivalence compares the bioavailability of two drug products.
Absolute Bioavailability: Compares non-intravenous administration to intravenous (IV) administration.
Relative Bioavailability: Compares two formulations or routes of the same drug.
Key Parameters:
Area Under the Curve (AUC)
Peak plasma concentration ()
Time to peak ()
Bioequivalence: Two products are bioequivalent if their rate and extent of absorption do not show significant differences.
Pharmaceutics Classification System
Drugs are classified based on solubility and permeability:
Class | Solubility | Permeability |
|---|---|---|
I | High | High |
II | Low | High |
III | High | Low |
IV | Low | Low |
Drug Stability and Shelf Life
Stability refers to the ability of a drug product to retain its properties over time. Shelf life is the period during which the product remains fit for use.
Chemical Stability: Integrity and potency
Physical Stability: Appearance, dissolution, uniformity
Microbiologic Stability: Sterility, antimicrobial effectiveness
Therapeutic Stability: Unchanged therapeutic effect
Toxicologic Stability: No significant increase in toxicity
Reaction Kinetics: Determines shelf life and expiration dates.
Zero-Order Reaction: Rate independent of concentration
First-Order Reaction: Rate proportional to concentration
Half-life Equations:
Zero-order:
First-order:
Q10 Method: Used to estimate shelf life at different temperatures.
= temperature coefficient (commonly 2-4)
= time for 10% degradation
Enhancing Drug Stability
Antioxidants (e.g., ascorbic acid)
Preservatives (prevent microbial growth)
Chelating agents (prevent metal-catalyzed oxidation)
Buffering agents (adjust pH)
Light-resistant containers (for light-sensitive drugs)
Summary Table: Types of Drug Equivalence
Type | Description |
|---|---|
Pharmaceutical Equivalent | Identical active ingredient, strength, dosage form, route |
Pharmaceutical Alternative | Same therapeutic moiety, may differ in form or salt |
Bioequivalent | No significant difference in rate/extent of absorption |
Therapeutic Equivalent | Pharmaceutical equivalent + bioequivalent |
Additional info:
Bioavailability studies are required for new drug applications and generic drug approval.
Dissolution testing is standardized by USP and uses simulated gastric/intestinal fluids.
Formulation changes can impact absorption rate and clinical effectiveness.